Prescription of DPP-4 Inhibitors to Type 2 Diabetes Mellitus Patients With Renal Impairment: A UK Primary Care Experience-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Prescription of DPP-4 Inhibitors to Type 2 Diabetes Mellitus Patients With Renal Impairment: A UK Primary Care Experience

Published:2018-01 Issue:1 Volume:40 Page:152-154
ISSN:0149-2918
Container-title:Clinical Therapeutics
language:en
Short-container-title:Clinical Therapeutics

Author:

Spanopoulos Dionysis,Barrett Brendan,Busse Michael,Roman Toni,Poole Chris

Publisher

Elsevier BV

Subject

Pharmacology (medical),Pharmacology

Reference7 articles.

1. Demographic and Clinical Characteristics of Patients With Type 2 Diabetes Mellitus Initiating Dipeptidyl Peptidase 4 Inhibitors: A Retrospective Study of UK General Practice;Tebboth;Clin Ther,2016

2. Glomerular filtration rate and albuminuria for detection and staging of acute and chronic kidney disease in adults: a systematic review;Levey;JAMA,2015

3. Januvia® (Sitagliptin). Summary of product characteristics. https://www.medicines.org.uk/emc/medicine/19609. Accessed June 15, 2017.

4. ONGLYZA® (saxagliptin). Summary of product characteristics. https://www.medicines.org.uk/emc/medicine/22315. Accessed June 15, 2017.

5. Vipidia® (Alogliptin). Summary of product characteristics. https://www.medicines.org.uk/emc/medicine/28513. Accessed June 15, 2017.

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Financial Benefits of Renal Dose-Adjusted Dipeptidyl Peptidase-4 Inhibitors for Patients with Type 2 Diabetes and Chronic Kidney Disease;Endocrinology and Metabolism;2024-08-31

2. Cumplimiento de las recomendaciones de ajuste de la dosis de inhibidores DPP4 según la función renal en una base de datos poblacional;Endocrinología, Diabetes y Nutrición;2022-02

3. Compliance with the DPP-4 inhibitors dose adjustment recommendations based on renal function in a population database;Endocrinología, Diabetes y Nutrición (English ed.);2022-02

4. Dipeptidyl peptidase 4 inhibitors in the treatment of type 2 diabetes mellitus;Nature Reviews Endocrinology;2020-09-14

5. EFFICACY AND MECHANISM OF ACTION OF MORINGA OLEIFERA IN DIABETES;INTERNATIONAL JOURNAL OF PHARMACEUTICAL SCIENCES AND RESEARCH;2020-09-01

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3